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Abstract
Incisional biopsy and intramedullary pinning were performed for pathological fracture associated with a malignant
bone tumor of the proximal humerus. Osteosarcoma, for which preoperative chemotherapy had been performed,
was confirmed by postoperative pathological examination. To achieve wide resection and acquire a safe resected
margin, total humerus replacement was performed, and the whole humerus was reconstructed using the
Howmedica Modular Reconstruction system. The patient resumed normal activities, although mild contracture of
the elbow joint remains 8 years after surgery.
Keywords: Total humerus replacement, Osteosarcoma
Background
Total humerus replacement following resection of a
malignant bone tumor of the upper limbs is a rarely
performed procedure [1]. We performed open reduction
and internal fixation simultaneously with incisional
biopsy in a patient with a bone tumor of the humerus,
pathological fracture of which had been caused by a
metastatic bone tumor or the primary malignant bone
tumor. Osteosarcoma was diagnosed, and total humerus
replacement was performed after chemotherapy. Preser-
vation of the affected limb was successful. In the 8
years, to date, since surgery the patient has remained
recurrence-free. Herein, we present this case in details.
Case presentation
The patient was a 48-year-old male with a chief com-
plaint of right upper arm pain. His past medical and
familial histories were unremarkable. On February 5,
2002, severe pain occurred in the right upper arm while
exercising with an iron bar, and he visited a physician.
The patient was referred and admitted to our depart-
ment for suspected pathological fracture associated with
a metastatic bone tumor on February 20. Swelling and
local heat were present in the proximal region of the
right forearm, and tenderness and pain during motion
were also present. No spontaneous pain was observed.
The range of motion of the right shoulder joint could
not be measured because of pain. On admission, alkali-
nephosphatase, at 442 and C-reactive protein at 1.05,
were both markedly elevated. All tumor markers were
negative, and there were no abnormal findings on other
tests.
On radiographs obtained at the first examination, a
pathological fracture was noted in the proximal
humerus, showing hypertranslucency of bone, mainly
involving osteolytic changes (Figure 1). On computed
tomography (CT), the bone cortex was thinned, and
showed a relatively homogenous structure. On magnetic
resonance imaging (MRI), a low intensity was observed
on T1-weighted imaging, while the fractured region was
mainly enhanced on T1 gadolinium contrast imaging,
and high intensity was observed on T2-weighted ima-
ging (Figure 2). Bone scintigraphy showed signal accu-
mulation in the proximal humerus. Based on these
findings, pathological fracture associated with a meta-
static bone tumor or primary malignant bone tumor in
the right proximal humerus was diagnosed, and inci-
sional biopsy and open reduction and internal fixation
(ORIF) were performed on February 25, 2002. The treat-
ment consisted of three Ender’s pins inserted at the pos-
terior aspect of the elbow joint. Swelling of the right
proximal upper arm became more severe after treat-
ment. On pathological examination, tumorous immature
bone tissue and osteoid were present; based on these
findings, an osteoblastic-type sarcoma was diagnosed.
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After about 4 months of preoperative chemotherapy
for osteosarcoma, sclerotic changes centered within the
area of bone hypertranslucency were observed on plain
X-ray and CT images. In addition, the accumulation on
bone scintigraphy disappeared. After preoperative che-
motherapy had been judged to have achieved a complete
response (CR), massive extra-capsular resection of the
shoulder joint was performed, followed by total humerus
placement on July 3, 2002. The humerus was entirely
resected including parts of the deltoid and triceps bra-
chii muscles and cuff, whereas the long head of the
biceps brachii muscle, musculocutaneous nerve, and
other neurovascular bundles were conserved. In recon-
struction of the cuff, an artificial ligament was attached
around an artificial bone head for tumor treatment, and
the artificial joint was entirely covered with a latissimus
dorsi muscle flap. In the postoperative specimen, the
lesion was completely and widely resected. Histopatho-
logically, the lesion was mostly necrotized, being close
to Grade 3 employing the tissue judgment scale estab-
lished by the Musculoskeletal Tumor Committee of the
Japanese Orthopaedic Association (Figure 3). Postopera-
tive chemotherapy was discontinued because of severe
liver dysfunction. As of 8 years after surgery, the
patient’s condition has remained favorable, with no local
recurrence or metastasis. Abduction, flexion and exten-
sion of the shoulder joint were 10, 20 and 5°, respec-
tively, external and internal rotations were -20 and 90°,
respectively, and flexion at the elbow joint was 20-120°.
The strengths of the biceps and triceps brachii muscles
were 4 and 2, respectively. The Enneking functional
score was 80%: pain, 5; function, 3; emotional accep-
tance, 3; hand positioning, 3; manual dexterity, 5; and
lifting ability, 3. On the International Society of Limb
Salvage X-ray evaluation, all items of bone remodeling,
interface, and anchorage were excellent.
Discussion
Osteosarcoma is a malignant tumor forming tumorous
bone and cartilage or osteoid. In the nationwide bone
tumor registry established by the Musculoskeletal
Tumor Committee of the Japanese Orthopaedic Asso-
ciation, 7,649 of a total of 49,768 bone tumors registered
from 1972 to 2003 (32 years) were malignant (15%);
3256 of these were osteosarcomas (accounting for 42%
of bone malignances). Development at 40 years of age
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Figure 1 Plain X-ray radiographs and MRI on the first examination. Osteolytic hypertranslucency accompanied by pathological fracture was
observed in the proximal humerus on plain radiographs. The periosteal reaction was not severe. On MRI, low intensity was detected on T1-
weighted imaging, while cyst-like changes and low intensity of the tumor content were seen on T1 gadolinium contrast imaging.
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or older is reportedly rare, but 433 (13.2%) of the 3,256
osteosarcoma patients were 40 years of age or older.
Regarding the developmental site, osteosarcoma most
frequently arises in the femur and tibia, followed by the
humerus in 262 cases (8%), being ranked the 3rd[1].
It is stated in Dahlin’s Bone Tumors that the inci-
dence in those in their 40s is about 5%, and that osteo-
sarcoma developed in the humerus in 154 of 1952 cases,
accounting for 7.8% of all osteosarcoma cases [2].
For the differential diagnosis from metastatic bone
tumor, which was a challenge in our present patient, a
comprehensive judgment should be based on past medi-
cal history, age, leison, and imaging findings. In patients
60 years of age and older, cancer metastasis is initially
suspected. The incidence of metastatic cancer is high in
the spine and pelvis, and the periosteal reaction on plain
radiographs is poor in a metastatic bone tumor. The pri-
mary lesion should also be simultaneously investigated.
In our present patient, bone destruction was marked,
and the periosteal reaction was poor. Arterial bone cyst,
giant cell tumor of bone, conventional osteosarcoma,
and telangiectatic osteosarcoma are included in the dif-
ferential diagnosis. Aneurysmal bone cyst was inconsis-
tent with age, and the developmental site was not
typical for giant cell tumor of bone [3]. Osteosarcoma,
particularly, telangiectatic osteosarcoma, was strongly
suspected on imaging, but a metastatic bone tumor was
also considered based on the patient’s age and the
higher prevalence of this type of tumor. Intramedullary
pinning was selected because plate fixation was difficult
due to the presence of pathological fracture and the
location of the lesion in the proximal humerus.
The challenge faced by surgeons after the resection of
a malignant bone tumor in the proximal humerus is
reconstruction of shoulder joint function. When the cuff
is included in massive resection to acquire a safe resec-
tion margin, shoulder joint function is mostly lost. For
reconstruction of the proximal end of the humerus, sev-
eral methods employing an artificial bone head for
tumor treatment [4], [5], allogeneic bone grafting [6],
[7], processed bone [8], and vascularized bone grafting
[9], [10]have been reported, but reconstruction by
Figure 2 Histopathology on biopsy and plain radiographics image at the completion of preoperative chemotherapy. Immature bone
tissue and osteoid were not reactive, and were judged to be tumorous. Osteoblastic-type osteosarcoma was ultimately diagnosed.
Chemotherapy was judged to have achieved a complete response (CR).
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hanging these from the acromion using an artificial liga-
ment, fascia, or tendon is inevitably necessary. We con-
sidered the distal humerus to be contaminated with
tumorcomponents via intramedullary pinning, and
adopted total humerus replacement to ensure the safety
of the resection margin.
For the proximal humerus, hanging from the acro-
mion using an artificial ligament was adopted. Our
resection method was corresponded closely with that
for type V of the Malawer classification of proximal
humeral malignant bone tumors, but we opted to per-
form massive resection corresponding to extra-capsu-
lar resection conserving the acromion and coracoid
process because chemotherapy had been sufficiently
effective [11]. Very few cases of total humerus replace-
ment have been reported. To our knowledge, only
Grimer (1996) [12] and Fabroni (1999) [4] have
reported such cases and Ayoub (1999) reported
described extendable artificial joint use for the
humerus [13]. Fabroni et al. reported long-term out-
comes in 3 cases, all receiving custom-made artificial
joints, and the mean functional score was about 65%.
The characteristics of the Howmedica Modular Recon-
struction System (HMRS) for the humerus used herein
include the adjustability of the stem length corre-
sponding to the resected bone mass and the presence
of a hole for attachment with soft tissue. In addition,
a porous coating is applied, and the ulnar component
of the elbow joint has an anatomical shape. However,
the level of osteotomy for optimal setting of the ulnar
component of the elbow joint is unclear, and improve-
ment may be necessary.
Conclusion
A pathological fracture due to a metastatic bone tumor
of the proximal humerus was initially diagnosed. Intra-
medullary pinning was performed. However, osteosar-
coma was confirmed by postoperative pathological
examinations. Therefore, preoperative chemotherapy
was conducted, followed by wide resection to acquire a
safe margin, and total humerus replacement was then
performed. The HMRS was used for reconstruction of
the whole humerus. The patient resumed normal activ-
ities, although mild contracture of the elbow joint
remains 8 years after surgery. In Japan, HMRS is the
only artificial joint for tumor treatment that covered
National Health Insurance. Reconstruction of the whole
humerus using HMRS is rare, but this reconstruction
Figure 3 Intraoperative findings and a postoperative plain radiographics images. Total humerus replacement was performed, and an
HMRS artificial joint for tumor treatment was inserted and hung using an artificial ligament. We used the Leeds-Keio as the artificial ligament for
this procedures. The ISOLS radiographics evaluation was excellent for all items.
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method is an options, by which a favorable limb func-
tion can be achieved.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
List of abbreviations
CT: Computed tomography; MRI: Magnetic resonance imaging; ORIF: Open
reduction and internal fixation; CR: Complete response; HMRS: Howmedica
Modular Reconstruction System
Authors’ contributions
YY contributed to collection of the clinical data and writing of the
manuscript. YT contributed to the writing and editing of the manuscript.
Both authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 June 2011 Accepted: 14 February 2012
Published: 14 February 2012
References
1. JOA Musculoskeletal tumor committee. Bone Tumor Registry in Japan.
National Cancer Center 2008.
2. Unni KK, Inwards CY: Dahlin’s Bone Tumors. Lippincott Wilianms&Wilikins ,
Sixth 2010.
3. Yarmish G, Klein MJ, Landa J, Lefkowitz RA, Hwang S: Imaging
characteristics of primary osteosarcoma: nonconventional subtypes.
Radiographics 2010, 30(6):1653-672.
4. Fabroni RH, Castago A, Aguilera AL, Steverlynck AM, Zeballous J: Long
-term results of limb salvage with the Fabroni custom made
endoprosthesis. Clin Orhtop Relat Res 1999, 35(8):41-52.
5. Ross AC, Sneath RS, Scales JT: Endoprosthetic replacement of the
humerus and elbow joint. J Bone Joint Surg [Br] 1987, 69-B:652-55.
6. Mankin HJ, Doppelt SH, Sullivan TR, Tomford WW: Osteoarticular and
intercalary allograft transplantation in the management of malignant
tumors of bone. Cancer 1982, 50:613-30.
7. Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW: Long-
term results of allograft replacement in the management of bone
tumors. Clin Orthop Relat Res 324 1996, 86-97.
8. Muramatsu K, Fukano R, Iwanaga R, Taguchi T: Reconstruction of the
proximal humerus by combined use of extracorporeally-irradiated
osteochondral graft and free vascularized fibula following resection of
Ewing sarcoma. Journal of Plastic, Reconstructive &Aesthetic Surgery 2010,
63:2177-180.
9. Wada T, Usui K, Isu K, Yamawakii S, Ishii S: Reconstruction and limb
salvage after resection for malignant bone tumour of the proximal
humerus. A single procedure using a free vasculaized fibular graft. J
Bone Join Surg 1999, 81B:808-13.
10. Rose PS, Shin AY, Bishop AT, Moran SL, Sim FH: Vascularized free fubula
transfer for oncogenic reconstruction of the humerus. Clin Orthop Relat
Res 2005, 438:80-4.
11. Bickels J, Wittig JC, Kollender Y, Kellar-Graney K, Meller I, Malawer MM:
Limb-sparing resections of the shoulder girdle. J Am Coll Surg 2002,
194(4):422-35.
12. Grimer JG, Carter SR, sneath SR: Manegement of a huge tumour of the
humerus by total replacement of the humerus:an 11-year foolow up.
Arch Orthop Trauma Surg 1998, 117:298-99.
13. Ayoub KS, Fiorenza F, Grimer RJ, Tilman SR, Carter RS: Extendable
endoprostheses of the humerus after resection of bone tumours. J Bone
Joint Surg [Br] 1999, 81-B:495-500.
doi:10.1186/1477-7819-10-36
Cite this article as: Yoshida and Tokuhashi: Total humerus replacement
for osteosarcoma with proximal part of humerus: a case report. World
Journal of Surgical Oncology 2012 10:36.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yoshida and Tokuhashi World Journal of Surgical Oncology 2012, 10:36
http://www.wjso.com/content/10/1/36
Page 5 of 5
